Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2831
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03084419 | APRIL (AbatacePt in Rheumatoid Arthritis-ILD) | ||
| NCT04817007 | A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis) | ||
| NCT01441973 | Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma | ||
| NCT04154800 | A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants | ||
| NCT03507699 | Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer | ||
| NCT03656627 | Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease | ||
| NCT00000954 | A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma | ||
| NCT04308681 | A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis | ||
| NCT02737475 | An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread | ||
| NCT04305899 | A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Adult Participants | ||
| NCT03800602 | Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer | ||
| NCT05426239 | Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database | ||
| NCT03241264 | A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body | ||
| NCT03660436 | An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants | ||
| NCT05064787 | Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy | ||
| NCT05337137 | A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer | ||
| NCT01152372 | Experimental Study to Validate the Modified Glucose Disposal Test | ||
| NCT02115139 | GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases | ||
| NCT00665444 | Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder | ||
| NCT00729664 | Multiple Ascending Dose (MDX1105-01) | ||
| NCT01420783 | Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia | ||
| NCT02343042 | Selinexor and Backbone Treatments of Multiple Myeloma Patients | ||
| NCT00284180 | Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer | ||
| NCT03172624 | Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer | ||
| NCT01455103 | Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma | ||
| NCT00895297 | Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia | ||
| NCT05621096 | Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma | ||
| NCT04895696 | A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) | ||
| NCT01192659 | Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes | ||
| NCT03317327 | REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors | ||
| NCT02339818 | Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries | ||
| NCT03891524 | A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery | ||
| NCT02346942 | Factors Associated With Biologic DMARD Switching | ||
| NCT01245556 | Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma | ||
| NCT02812524 | Ipilimumab for Head and Neck Cancer Patients | ||
| NCT06240754 | Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial | ||
| NCT03585465 | Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors | ||
| NCT02756481 | Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela | ||
| NCT00002293 | A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes | ||
| NCT02124044 | Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV | ||
| NCT00724334 | A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis | ||
| NCT01046864 | Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) | ||
| NCT03854032 | Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck | ||
| NCT02157506 | A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure | ||
| NCT03402087 | A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients | ||
| NCT03342352 | Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) | ||
| NCT00389155 | First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy | ||
| NCT02472977 | Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors | ||
| NCT03831438 | Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis | ||
| NCT05838781 | DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation |
